Invention Grant
- Patent Title: Modulation of gene expression in a human bioreactor
-
Application No.: US16773977Application Date: 2020-01-27
-
Publication No.: US11697834B2Publication Date: 2023-07-11
- Inventor: Annelise E. Barron , David Haase , Joshua McClure
- Applicant: Maxwell Biosciences, Inc.
- Applicant Address: US TX West Lake Hills
- Assignee: Maxwell Biosciences, Inc.
- Current Assignee: Maxwell Biosciences, Inc.
- Current Assignee Address: US TX Austin
- Agency: McDermott Will & Emery
- Main IPC: G01N33/50
- IPC: G01N33/50 ; C12Q1/68 ; A61K35/16

Abstract:
A method is provided for treating a recipient with a biological product obtained from at least one donor that may be the same as, or different from, the recipient. The method includes identifying a targeted level of gene expression of a first gene in a biological product to be transferred from at least one donor to a recipient; treating the at least one donor to achieve the targeted level of gene expression of the first gene in the biological product; and transferring the biological product from the at least one donor to the recipient.
Public/Granted literature
- US20200319209A1 MODULATION OF GENE EXPRESSION IN A HUMAN BIOREACTOR Public/Granted day:2020-10-08
Information query
IPC分类: